Skip to main content
Caplight Logo









Retro Biosciences

Retro Biosciences

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.retro.bio/

Last Round

Series A

May 22, 2026

Est. Valuation

$1.8B

Total Funding Raised

$180M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Retro Biosciences is a biotechnology company that develops therapeutics targeting cellular reprogramming, autophagy, and plasma-inspired mechanisms to extend healthy human lifespan.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

longevity biotechcellular reprogrammingprotein engineeringage-related diseasedrug discoveryanti-aginghealthspanAI drug discoverytherapeutic pipelinecellular rejuvenationAlzheimer's therapeuticsprotein designbiotech startuplife extensioncomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Retro Biosciences Comparables

Compare Retro Biosciences with similar companies based on industry and business-model similarity.

Retro Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NewLimit
88%
Altos Labs
87%
Rubedo Life Sciences
79%

Retro Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 22, 2026
SeedApr 6, 2022

Key People

Founding team and executive leadership

"Joe Betts-LaCroix"

CEO i.e. ultimately responsible for the achieving our mission

Executive Team

Retro Biosciences Investors

Notable investors and investment history

Retro Biosciences investors
InvestorRounds
4P CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 22, 2026

    Raised Series A led by 4P Capital

  • Oct 22, 2025

    Developing AI model for cell-repairing proteins with OpenAI.

Retro Biosciences Filings

Explore SEC and related filing metadata, where available.

Retro Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Retro Biosciences's valuation, stock price, and market status.

Is Retro a public or private company?

Retro is a private company.

What is the current stock price of Retro?

Retro is a private company with no public stock price. No recent secondary market data is available.

How much is Retro worth (valuation)?

Retro's valuation is estimated at $5.0B based on funding round data.

Can I buy Retro stock?

Retro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Retro's last funding round?

Retro's most recent funding round was Series A on January 24, 2025.

Who are the main investors in Retro?

Investor information for Retro is not publicly disclosed.

Will Retro IPO soon?

No public IPO plans have been announced for Retro.

How can I track Retro secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Retro's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range75
Year Founded2021
Last FundingMay 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?